Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice

Sushmita Rath; Prahalad Elamarthi; Pallavi Parab; Seema Gulia; Ravindra Nandhana; Smruti Mokal; Yogesh Kembhavi; Prema Perumal; Jyoti Bajpai; Jaya Ghosh; Sudeep Gupta

doi:10.1371/journal.pone.0253722

Loading metrics

Open Access

Peer-reviewed

Research Article

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice

Sushmita Rath ,

Contributed equally to this work with: Sushmita Rath, Prahalad Elamarthi

Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Prahalad Elamarthi ,

Contributed equally to this work with: Sushmita Rath, Prahalad Elamarthi

Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Pallavi Parab,

Roles Formal analysis, Project administration, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Seema Gulia,

Roles Data curation, Formal analysis, Supervision, Writing – original draft, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Ravindra Nandhana,

Roles Data curation, Formal analysis, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Smruti Mokal,

Roles Formal analysis, Writing – review & editing

Affiliation Department of Biostatistics, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Yogesh Kembhavi,

Roles Project administration, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Prema Perumal,

Roles Project administration, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Jyoti Bajpai,

Roles Data curation, Supervision, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Jaya Ghosh,

Roles Supervision, Writing – review & editing

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
⨯
Sudeep Gupta

Roles Conceptualization, Data curation, Formal analysis, Methodology, Supervision, Writing – original draft, Writing – review & editing

* E-mail: sudeepgupta04@yahoo.com

Affiliation Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

https://orcid.org/0000-0002-6742-6378

⨯

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice

Sushmita Rath,
Prahalad Elamarthi,
Pallavi Parab,
Seema Gulia,
Ravindra Nandhana,
Smruti Mokal,
Yogesh Kembhavi,
Prema Perumal,
Jyoti Bajpai,
Jaya Ghosh

Published: July 22, 2021
https://doi.org/10.1371/journal.pone.0253722

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Endocrine therapy
Is the Subject Area "Endocrine therapy" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Neutropenia
Is the Subject Area "Neutropenia" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Regression analysis
Is the Subject Area "Regression analysis" applicable to this article?

Thanks for your feedback.
Progesterone
Is the Subject Area "Progesterone" applicable to this article?

Thanks for your feedback.